Androgen Axis Suppression

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Androgen Axis Suppression trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT06274047

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life i…

1. Personalize treatment for prostate cancer based on how aggressive the disease is and 2. Learn if apalutamide-based treatment can help to reduce fatigue and o…

United States120 participantsStarted 2024-09-10

Treatment: Apalutamide, Androgen Deprivation Therapy

All recent trials (2 shown)

CompletedPhase 2

NCT00298155

Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer

Prostate cancer (CaP) is the most commonly diagnosed cancer among males in the U.S. and the second leading cause of cancer-related mortality. More than 230,000…

United States35 participantsStarted 2006-07

Treatment: goserelin with dutasteride, goserelin with bicalutamide and dutasteride